A clinical evaluation of placental growth factor in routine practice in high-risk women presenting with suspected pre-eclampsia and/or fetal growth restriction-Reference-Cited by-同舟云学术

A clinical evaluation of placental growth factor in routine practice in high-risk women presenting with suspected pre-eclampsia and/or fetal growth restriction

Published:2018-10 Issue: Volume:14 Page:234-239
ISSN:2210-7789
Container-title:Pregnancy Hypertension
language:en
Short-container-title:Pregnancy Hypertension

Author:

Ormesher L.,Johnstone E.D.,Shawkat E.,Dempsey A.,Chmiel C.,Ingram E.,Higgins L.E.,Myers J.E.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Internal Medicine

Reference22 articles.

1. Saving Lives, Improving Mothers’ Care: Lessons learned to inform future maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009-12;Knight,2014

2. Maternal and fetal risk factors for stillbirth: population based study;Gardosi;BMJ,2013

3. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study;Chappell;Hypertension,2008

4. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP;Tranquilli;Pregnancy Hypertens.,2014

5. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study;Chappell;Circulation,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does the use of angiogenic biomarkers for the management of preeclampsia and fetal growth restriction improve outcomes?: Challenging the current status quo;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-09

2. Materno‐fetal outcome with PlGF above or below cutoff during second half of pregnancy in high‐risk women;International Journal of Gynecology & Obstetrics;2023-10-10

3. Guideline No. 442: Fetal Growth Restriction: Screening, Diagnosis, and Management in Singleton Pregnancies;Journal of Obstetrics and Gynaecology Canada;2023-10

4. Directive clinique no 442 : Retard de croissance intra-utérin : Dépistage, diagnostic et prise en charge en contexte de grossesse monofœtale;Journal of Obstetrics and Gynaecology Canada;2023-10

5. Toward a new taxonomy of obstetrical disease: improved performance of maternal blood biomarkers for the great obstetrical syndromes when classified according to placental pathology;American Journal of Obstetrics and Gynecology;2022-10